Cancer Staging: Important Work of the AJCC

Jeffrey E. Gershenwald, MD, FACS, Dr. John M. Skibbter Professor, Dept. of Surgical Oncology; Professor, Department of Cancer Biology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX; Member, American Joint Committee on Cancer (AJCC) Executive Committee; Member, AJCC Eighth Edition Editorial Board (Melanoma Expert Panel & Content […]

Foundation Medicine, CMS, FDA, CAP and Academic Molecular Pathology: A Clash of Values

Karen Kaul MD, PhD, Chair, Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem; , Duckworth Family Chair of Molecular Pathology; Clinical Professor of Pathology, University of Chicago Pritzker School of Medicine; Chicago, IL; Email: Follow Q: The field of precision oncology continues to seek clear guidance on payment for both molecular testing and […]

Do you have pain, cancer, or diabetes? Your PBM may now be your doctor for these illnesses.

Charles L. Bennett MD PhD MPP, Smart State and Frank P and Jose M Fletcher Chair, Medication Safety and Efficacy, Smart State Center of Economic Excellence, University of South Carolina and the Hollings Cancer Center at the Medical University of South Carolina; Charleston, South Carolina; Email: Q: The opioid epidemic is now a public […]

Using High Content Imaging for Biomarker Discovery to Support Precision Oncology

Gavin J. Gordon, MBA, PhD, Vice President of Commercial Operations at Fluidigm Corporation, South San Francisco, CA Email: Placeholder Q: Huge new advances in technology continue to illuminate the research and translational space. How do you think your new product the Hyperion Imaging System is likely to influence precision medicine testing? A: The Hyperion™ […]

Challenging Oncology Therapies With Moonshot Price Tags

Pramod John, PhD, CEO, VIVIO Health, San Leandro, CA; Email: Placeholder Placeholder Q: Some American pharmaceutical companies are well-known for pricing drugs at “whatever the market will bear”. In oncology, some specialty drugs seem to have price tags completely unrelated to the proven effectiveness of the drug. Your company has been taking a lead […]

Accuracy and Precision Define Radiation Oncology

Eddy Yang, MD, PhD, Professor and Vice Chair of Translational Sciences Department of Radiation Oncology; Deputy Director, Associate Director of Precision Oncology at the Hugh Kaul Precision Medicine Institute; Birmingham, AL; Email: Follow Eddy Q: You are a radiation oncologist with a particular interest in cancer of the prostate. How does the molecular study […]

Precision Oncology in the UK in 2017

Justin Stebbing, MA FRCP FRCPath PhD, Professor of Cancer Medicine and Medical Oncology at the Imperial College/Imperial Healthcare NHS Trust Charing Cross Hospital, London, UK; Email: Q: Science is universal but the practice of medicine varies widely by geography, economics, and culture. The United Kingdom is an advanced developed country with universal healthcare. How […]

Using Data Analytics to Make an Impact in Brain Cancer

Lisandra West-Odell, PhD, Scientist and Product Manager, Cancer Commons, Los Altos, CA; Email: Follow Lisandra Q: Reflecting the current reality of a brain cancer diagnosis, how can Cancer Commons positively impact the treatment and outcome of each patient diagnosed with brain cancer? A: Just over two and a half years ago the March 30, […]

Life After Oncology

Professor Michael Baum, Professor Emeritus of Surgery & Visiting Professor of Medical Humanities, University College, London, UK; Email: Q: You have recently decided to “withdraw from the field” after a distinguished multi-decade career in Surgical Oncology. Many of our readers will confront a similar choice. How do you see your life evolving from here […]

Huge Progress in Palliative Care

Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care; Professor of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai; New York, NY; Email: Follow Diane Q: You wrote in MedGenMed in 2007 that palliative care was the job of all hospitals (MedGenMed 2007; 9(3) 6. July 7. PMCID:PMC2100088). In […]